Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Ratio (2022 - 2025)

Envoy Medical's Equity Ratio history spans 4 years, with the latest figure at 0.94 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 52.54% year-over-year to 0.94; the TTM value through Sep 2025 reached 0.94, up 52.54%, while the annual FY2024 figure was 1.63, 660.52% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.94 at Envoy Medical, up from 3.02 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.23 in Q3 2023 and bottomed at 14.16 in Q4 2022.
  • The 4-year median for Equity Ratio is 1.0 (2023), against an average of 1.93.
  • The largest YoY upside for Equity Ratio was 477.81% in 2023 against a maximum downside of 1623.26% in 2023.
  • A 4-year view of Equity Ratio shows it stood at 14.16 in 2022, then soared by 98.48% to 0.21 in 2023, then plummeted by 660.52% to 1.63 in 2024, then skyrocketed by 42.66% to 0.94 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Equity Ratio are 0.94 (Q3 2025), 3.02 (Q2 2025), and 2.33 (Q1 2025).